High triglyceride causes: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
Line 18: | Line 18: | ||
{|style="width:80%; height:100px" border="1" | {|style="width:80%; height:100px" border="1" | ||
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | |style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular''' | ||
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | | |style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Alström syndrome]], [[apolipoprotein E|apoprotein E deficiency]], [[high chylomicron|chylomicron levels raised (plasma)]], [[familial chylomicronemia]], [[familial combined hyperlipidemia]], [[familial hypertriglyceridemia]], [[hyperlipoproteinemia type V|hyperlipoproteinemia, familial type 5]], [[IDL|intermediate density lipoprotein levels raised (plasma or serum)]] | ||
|- | |- | ||
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | |bgcolor="LightSteelBlue"| '''Chemical/Poisoning''' | ||
Line 29: | Line 29: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Dermatologic''' | | '''Dermatologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical antipsychotics]], [[bendrofluazide]], [[beta-blockers]], [[bexarotene]], [[chlorthalidone]], [[clomiphene]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive pill]], [[desvenlafaxine]], [[diuretics]], [[estrogen replacement therapy]], [[fosamprenavir]], [[glucocorticoids]], [[hydrochlorothiazide]], [[interferon alpha]], [[linagliptin]], [[lopinavir]], [[mirtazapine]], [[non-nucleoside reverse transcriptase inhibitors]], [[olanzapine]], [[isotretinoin|oral isotretinoin]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[saquinavir]], [[tamoxifen]], [[temsirolimus]], [[tipranavir]], [[tocilizumab]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 41: | Line 41: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Cushing's syndrome]], [[diabetes mellitus]], [[hypothyroidism]], [[insulin resistance]], [[metabolic syndrome]], [[polycystic ovary syndrome]], [[reaven syndrome|Reaven syndrome X]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 49: | Line 49: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Gastroenterologic''' | | '''Gastroenterologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"|[[Acute pancreatitis]], [[Alagille syndrome]], [[carnitine palmitoyltransferase 1 deficiency]], [[cholesteryl ester storage disease]], [[glycogen storage disease|glycogen storage disease type 1]], [[glycogenosis type 1a]], [[liver cirrhosis]], [[non-alcoholic fatty liver disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Alagille syndrome]], [[Alström syndrome]], [[apolipoprotein E|apoprotein E deficiency]], [[carnitine palmitoyltransferase 1 deficiency]], [[cholesteryl ester storage disease]], [[congenital generalized lipodystrophy|congenital generalized lipodystrophy type 1]], [[apolipoprotein C2|deficiency of apolipoprotein C2 ]], [[familial chylomicronemia]], [[familial combined hyperlipidemia]], [[familial histiocytic reticulosis]], [[familial hypertriglyceridemia]], [[fish eye disease]], [[glycogen storage disease|Glycogen storage disease type 1]], [[glycogenosis type 1a]], [[hyperlipoproteinemia type V|hyperlipoproteinemia, familial type 5]], [[lecithin cholesterol acyltransferase deficiency]], [[metabolic syndrome]], [[Niemann-Pick disease|Niemann-Pick disease type B]], [[reaven syndrome|Reaven syndrome X]], [[sphingomyelinase deficiency]], [[Tangier disease]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Familial histiocytic reticulosis]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Iatrogenic''' | | '''Iatrogenic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Parenteral nutrition]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 69: | Line 69: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Musculoskeletal/Orthopedic''' | | '''Musculoskeletal/Orthopedic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Systemic lupus erythematosus]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Niemann-Pick disease|Niemann-Pick disease type B]], [[sphingomyelinase deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Alcohol]], | |||
[[Apoprotein E deficiency]], | |||
[[Chylomicron levels raised (plasma)]], | |||
[[Deficiency of apolipoprotein C2 ]], | |||
[[Familial chylomicronemia]], | |||
[[Familial combined hyperlipidemia]], | |||
[[Familial hypertriglyceridemia]], | |||
[[Glycogen storage disease type 1]], | |||
[[Glycogenosis type 1a]], | |||
[[High carbohydrate or high glycemic index]], | |||
[[Hyperlipoproteinemia, familial type 5]], | |||
[[Intermediate density lipoprotein levels raised (plasma or serum)]], | |||
[[Lipodystrophy]], | |||
[[Lipoprotein lipase deficiency]], | |||
[[Obesity]], | |||
[[Tangier disease]], | |||
[[Very low density lipoprotein levels raised (plasma or serum)]], | |||
[[Vitamin E deficiency, familial isolated]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Obstetric/Gynecologic''' | | '''Obstetric/Gynecologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Polycystic ovary syndrome]], | |||
[[Pregnancy]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 89: | Line 130: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Ophthalmologic''' | | '''Ophthalmologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Diabetes mellitus]], | |||
[[Lecithin cholesterol acyltransferase deficiency]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Overdose/Toxicity''' | | '''Overdose/Toxicity''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Alcohol]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 105: | Line 152: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Renal/Electrolyte''' | | '''Renal/Electrolyte''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Chronic kidney disease]], | |||
[[Chronic renal insufficiency]], | |||
[[Diabetes mellitus]], | |||
[[Nephrotic syndrome]], | |||
[[Systemic lupus erythematosus]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Macrophage activation syndrome]], | |||
[[Metabolic syndrome]], | |||
[[Paraproteinemias]], | |||
[[Reaven syndrome X]], | |||
[[Systemic lupus erythematosus]], | |||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 125: | Line 192: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Miscellaneous''' | | '''Miscellaneous''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| | ||
[[Alcohol]], | |||
|- | |- | ||
|} | |} |
Revision as of 16:11, 25 September 2013
Triglyceride Microchapters |
Clinical Correlation |
---|
Treatment |
Case Studies |
High triglyceride causes On the Web |
American Roentgen Ray Society Images of High triglyceride causes |
Risk calculators and risk factors for High triglyceride causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]
Overview
Hypertriglyceridemia can occur due to various causes, including genetics, familial, metabolic and drugs
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP (2009). "Primary and secondary hypertriglyceridaemia". Curr Drug Targets. 10 (4): 336–43. PMID 19355858.
- ↑ Fallat RW, Glueck CJ (1976). "Familial and acquired type V hyperlipoproteinemia". Atherosclerosis. 23 (1): 41–62. PMID 1078394.